We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

97 hedge funds and large institutions have $401M invested in Accelerate Diagnostics in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 15 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 15

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

59% more capital invested

Capital invested by funds: $252M → $401M (+$149M)

10% more funds holding

Funds holding: 88 → 97 (+9)

12% less call options, than puts

Call options by funds: $3.03M | Put options by funds: $3.46M

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
97
Holders Change
+9
Holders Change %
+10.23%
% of All Funds
2.55%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
22
Increased
39
Reduced
15
Closed
11
Calls
$3.03M
Puts
$3.46M
Net Calls
-$428K
Net Calls Change
+$1.56M

Top Buyers

1
MGM
Miura Global Management
New York
+$16.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.8M
3
N
Nuveen
North Carolina
+$5.32M
4
OIM
Oracle Investment Management
Connecticut
+$3.97M
5
DCM
Driehaus Capital Management
Illinois
+$2.9M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$2.16M
2
RCM
Raging Capital Management
New Jersey
-$1.41M
3
Group One Trading
Group One Trading
Illinois
-$1.13M
4
CS
Credit Suisse
Switzerland
-$606K
5
Stifel Financial
Stifel Financial
Missouri
-$518K
Name Holding Trade Value Shares
Change 		Change in
Stake
OIM
1
Oracle Investment Management
Connecticut
$121M +$3.97M +21,765 +4%
BC
2
Birchview Capital
Vermont
$46.3M +$1.61M +8,824 +4%
MGM
3
Miura Global Management
New York
$32.2M +$16.4M +90,000 +150%
Vanguard Group
4
Vanguard Group
Pennsylvania
$21.6M +$2.59M +14,202 +16%
CC
5
Cannell & Co
New York
$21.2M +$537K +2,941 +3%
JMPWA
6
JP Morgan Private Wealth Advisors
California
$16.3M – – –
Fidelity Investments
7
Fidelity Investments
Massachusetts
$12.7M +$10.8M +59,000 New
BIT
8
BlackRock Institutional Trust
California
$12.2M +$1.06M +5,828 +11%
BFA
9
BlackRock Fund Advisors
California
$11.5M +$413K +2,262 +4%
ACH
10
ArrowMark Colorado Holdings
Colorado
$7.97M +$2.84M +15,546 +72%
State Street
11
State Street
Massachusetts
$7.73M +$152K +834 +2%
William Blair Investment Management
12
William Blair Investment Management
Illinois
$7.18M +$2.74M +15,036 +82%
SM
13
Selkirk Management
New Jersey
$6.93M +$1.41M +7,750 +32%
OWP
14
Obermeyer Wealth Partners
Colorado
$5.94M – – –
TCM
15
Tekla Capital Management
Massachusetts
$5.69M +$2.19M +12,000 +83%
Northern Trust
16
Northern Trust
Illinois
$5.67M +$437K +2,392 +10%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$3.81M +$295K +1,615 +10%
IHM
18
Iguana Healthcare Management
New York
$3.76M +$456K +2,500 +17%
DCM
19
Driehaus Capital Management
Illinois
$3.41M +$2.9M +15,881 New
VAM
20
Visium Asset Management
New York
$3.22M +$2.74M +15,000 New
UBS Group
21
UBS Group
Switzerland
$2.74M +$776K +4,254 +50%
Alyeska Investment Group
22
Alyeska Investment Group
Illinois
$2.69M +$2.28M +12,500 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$2.65M +$262K +1,434 +13%
DA
24
DSC Advisors
Illinois
$2.45M +$344K +1,886 +20%
ACA
25
Avoro Capital Advisors
New York
$2.43M +$2.06M +11,289 New
1
2 3 4 5

AXDX Hedge Fund Activity: Q4 2015 in Review

97 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q4 2015, worth a combined $401M — up 59% from $252M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new AXDX positions and 11 closed out — a net gain of 11 holders — while 39 added to existing stakes and 15 trimmed.

The largest buyer was Miura Global Management, adding an estimated $16.4M. The largest seller was Millennium Management, cutting an estimated $2.16M.

  • 97 institutional investors held Accelerate Diagnostics (AXDX) as of Q4 2015, up from 88 in Q3 2015.
  • Funds reported $401M of Accelerate Diagnostics stock for Q4 2015, up 59% quarter-over-quarter.
  • 22 funds opened new Accelerate Diagnostics positions in Q4 2015 and 11 closed out, a net change of +11 holders.
  • The largest Accelerate Diagnostics buyer in Q4 2015 was Miura Global Management, an estimated $16.4M added.
  • The largest Accelerate Diagnostics seller in Q4 2015 was Millennium Management, an estimated $2.16M sold.

Based on aggregated 13F filings for Q4 2015.